MicroPort Scientific Corp (853):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MicroPort Scientific Corp (853) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7018
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, electrophysiological devices, neurovascular devices, diabetes care and endocrinal; and surgical management products. MicroPort also provides products for coronary drug eluting stents, artificial joints, aortic stents, cerebral vascular stents and electrophysiology equipment. The company sells its products through a network of distributors in Asia, North America, South America and Europe. MicroPort is headquartered in Shanghai, China.

MicroPort Scientific Corp (853) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MicroPort Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MicroPort Scientific Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MicroPort Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MicroPort Scientific Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MicroPort Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MicroPort Scientific Corp, Medical Equipment, Deal Details 11
Venture Financing 11
Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 11
Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 12
Zenomics Raises USD5.8 Million in Financing 13
Private Equity 14
MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 14
Partnerships 16
ConforMIS Enters into Licensing Agreement with MicroPort Orthopedics 16
MicroPort Scientific to Enter into Distribution Agreement with Promaxo 17
Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 18
MicroPort Scientific Enters into Agreement with MinInvasive 19
MicroPort Orthopedics Enters into Co-Development Agreement with MB Innovations for Orthopedic Instruments 20
MicroPort Scientific Forms Joint Venture with Sorin 21
ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 22
Equity Offering 23
MinInvasive Raises Funds through Private Placement of Shares 23
Debt Offering 24
MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 24
Acquisition 25
MicroPort Scientific Plans To Acquire Medical Device Company 25
MicroPort Acquires D-Pulse Medical 26
MicroPort Scientific Acquires Winning Forward For US$5.3 Million 27
MicroPort Scientific Corp – Key Competitors 28
MicroPort Scientific Corp – Key Employees 29
MicroPort Scientific Corp – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 31
Recent Developments 32
Strategy And Business Planning 32
Jul 24, 2017: MicroPort and Shanghai East Hospital Establish Translational Medicine Joint Research Center 32
Financial Announcements 33
Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 33
Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 35
Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 36
Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 38
Mar 30, 2017: MPSC Announces 2016 Annual Results 39
Corporate Communications 41
Jun 21, 2018: MicroPort Scientific Announces Change Of Non-Executive Director 41
May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 42
Jul 07, 2017: MPSC New COO Glendy Wang on Board 43
Legal and Regulatory 44
Jul 06, 2018: Shanghai MicroPort Medical (Group) Won a Patent Right Lawsuit Against NewMed Medical 44
Government and Public Interest 45
Jun 07, 2017: MicroPort Hosts 2017 Coronary Product Distributor Conference 45
Product News 46
Jun 27, 2018: MicroPort CRM Held the 12th Edition of New Horizons Scientific Conference 46
Jun 27, 2018: MicroPort Hosts the Sixth Science and Technology Conference 47
Jan 08, 2018: MicroPort Orthopedics Attends 12th COA 48
Nov 24, 2017: MicroPort Attends Ninth Indonesian Society of Interventional Cardiology Annual Meeting 50
Nov 24, 2017: MicroPort NeuroTech Attends 17th OCIN 51
Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 52
Other Significant Developments 53
Aug 30, 2018: MicroPort CRM announces change in strategic direction for Japan CRM market and end of distribution agreement with JLL in One Year’s Time 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
MicroPort Scientific Corp, Medical Equipment, Key Facts, 2017 2
MicroPort Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MicroPort Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MicroPort Scientific Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MicroPort Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MicroPort Scientific Corp, Deals By Market, 2012 to YTD 2018 9
MicroPort Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 11
Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 12
Zenomics Raises USD5.8 Million in Financing 13
MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 14
ConforMIS Enters into Licensing Agreement with MicroPort Orthopedics 16
MicroPort Scientific to Enter into Distribution Agreement with Promaxo 17
Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 18
MicroPort Scientific Enters into Agreement with MinInvasive 19
MicroPort Orthopedics Enters into Co-Development Agreement with MB Innovations for Orthopedic Instruments 20
MicroPort Scientific Forms Joint Venture with Sorin 21
ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 22
MinInvasive Raises Funds through Private Placement of Shares 23
MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 24
MicroPort Scientific Plans To Acquire Medical Device Company 25
MicroPort Acquires D-Pulse Medical 26
MicroPort Scientific Acquires Winning Forward For US$5.3 Million 27
MicroPort Scientific Corp, Key Competitors 28
MicroPort Scientific Corp, Key Employees 29
MicroPort Scientific Corp, Other Locations 30
MicroPort Scientific Corp, Subsidiaries 30
MicroPort Scientific Corp, Joint Venture 31

List of Figures
MicroPort Scientific Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MicroPort Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MicroPort Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MicroPort Scientific Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MicroPort Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MicroPort Scientific Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MicroPort Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MicroPort Scientific Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[MicroPort Scientific Corp (853):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Knoll, Inc.:企業の戦略・SWOT・財務情報
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Targovax ASA (TRVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Altium Ltd:企業の戦略・SWOT・財務分析
    Altium Ltd - Strategy, SWOT and Corporate Finance Report Summary Altium Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kuwait Oil Co:企業の戦略的SWOT分析
    Kuwait Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Angelique International Ltd:企業の戦略・SWOT・財務情報
    Angelique International Ltd - Strategy, SWOT and Corporate Finance Report Summary Angelique International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • IB Pharmaceuticals Inc (INNT):製薬・医療:M&Aディール及び事業提携情報
    Summary IB Pharmaceuticals Inc (IB Pharmaceuticals), formerly Innovate Biopharmaceuticals Inc, is a clinical-stage biotechnology company that discovers and develops novel medicines for orphan and gastroenterological disorders. The company’s pipeline includes INN-108 intended for inflammatory bowel d …
  • Cintas Corp (CTAS):企業の財務・戦略的SWOT分析
    Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Steatite Limited:企業の戦略・SWOT・財務情報
    Steatite Limited - Strategy, SWOT and Corporate Finance Report Summary Steatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Taisei Lamick Co., Ltd.:企業の戦略・SWOT・財務情報
    Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Airest S.p.A.:企業の戦略・SWOT・財務情報
    Airest S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Airest S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Korea Gas Corp (036460):企業の財務・戦略的SWOT分析
    Korea Gas Corp (036460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Blue Coat Systems, Inc.:企業のM&A・事業提携・投資動向
    Blue Coat Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blue Coat Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Mesoblast Ltd (MSB):製薬・医療:M&Aディール及び事業提携情報
    Summary Mesoblast Ltd (Mesoblast) is a regenerative medicine company, which develops regenerative cell-based products. Its pipeline product candidates include MPC-150-IM, which is under development for the treatment of chronic congestive heart failure; MSC-100-IV, for the treatment of acute graft ve …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆